Pfizer Ventures

Funding rounds backed by Pfizer Ventures.

Export CSV
Funding disclosed in full
$259.2M
Median round
$50M
Rounds in calculation
5
5 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
TRIMTECH Therapeutics

Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases

$47MSeed+BiotechUnited Kingdom
11 participantsBGFCambridge Enterprise VenturesCambridge Innovation CapitalDDFEli Lilly and CompanyInc.Johnson & Johnson Innovation – JJDCMP Healthcare Venture ManagementM VenturesPfizer VenturesStart Codon
Crossbow Therapeutics

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

$77MSeries BBiotechUnited States
13 participantsArkin Bio CapitalBlood Cancer United's Therapy Acceleration ProgramBVF PartnersEli Lilly and CompanyHamilton Square PartnersLibbs VenturesLifeLink VenturesMirae Asset Venture InvestmentMPM BioImpactPfizer VenturesPolaris PartnersSixty Degree CapitalTaiho Ventures
TRex Bio

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosedBiotechUnited States
11 participantsAffinity Asset AdvisorsAlexandria Venture InvestmentsAvego BioScience CapitalBalyasny Asset ManagementDelos CapitalEli Lilly and CompanyJanus Henderson InvestorsJohnson & Johnson Innovation – JJDCPfizer VenturesPolaris PartnersSV Health Investors
Vibrant Therapeutics

Develops intelligent, logic-gated therapeutics for solid tumors

$61MSeries ABiotechChina
6 participantsApricot CapitalBayland CapitalFirst Principle Venture LimitedHSGNorthern Light Venture CapitalPfizer Ventures
Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

€20.7MSeedBiotechFrance
10 participantsArgobio StudioBpifranceElaiaInvestSudMACSFMission BioCapitalPfizer VenturesSambrinvestThe Institut PasteurWallonie Entreprendre